Skip to main content

What the FDA labels say about taking them together

Bevacizumab and sunitinib

Sunitinib's FDA label of February 20, 2026 names bevacizumab in its warnings and precautions section; the bevacizumab labels PlainMeds reads (4) do not name sunitinib.

Check it at the source: the bevacizumab FDA label on DailyMed (effective March 23, 2026, Amneal Pharmaceuticals LLC); the sunitinib FDA label on DailyMed (effective February 20, 2026, Pfizer Laboratories Div Pfizer Inc).

What does the bevacizumab label say about sunitinib?

Bevacizumab's label (effective March 23, 2026) and its 3 other brand-application labels do not name sunitinib in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (ALYMSYS), Amneal Pharmaceuticals LLC, effective March 23, 2026 (SPL set 6b4040a2-a5c5-4ff0-ab45-935d7e49cf78), via openFDA; the full label on DailyMed

What does the sunitinib label say about bevacizumab?

Sunitinib label, warnings and precautions

Microangiopathy (TMA) Thrombotic Microangiopathy (TMA), including thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, sometimes leading to renal failure or a fatal outcome, occurred in clinical trials and in postmarketing experience of SUTENT as monotherapy and administered in combination with bevacizumab.

Source: FDA drug label (SUTENT), NDA021938 (Cppi Cv), as published by Pfizer Laboratories Div Pfizer Inc, effective February 20, 2026 (SPL set 43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Bevacizumab generic labelers
8Sunitinib generic labelers
BevacizumabSunitinib
Labeled forColorectal cancer, Lung cancern/a
Boxed warningNoYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?